ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Taipei Medical University at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Taipei Medical University takes part in 3 sessions at ESMO 2026 in Madrid. Its work covers liver and neuroendocrine cancers and treatment response across cancer types. The studies examine outcomes by liver cancer cause, drug-response patterns and survival by neuroendocrine tumour origin.

OrganizationESMO 2026 Attendance
Taipei Medical University
Taipei City, Taiwan
University & institute
Medical university in Taipei City, Taiwan.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Mon Oct 26
12:00–12:45
Primary-site classification (GI vs non-GI vs CUP) stratifies overall survival in neuroendocrine neoplasms: A real-world matched cohort study
Monday Poster Display session 3
Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Taipei Medical University

Tell us what you sell and we’ll find the people at Taipei Medical University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction